Spasticity

• CLINICAL_TRIALS trial_result · 2008-11-04
  Clinical Trial Update: Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury [Phase 2]

  Phase 2 trial of AV650 for spasticity due to spinal cord injury was terminated; the update reports safety and preliminary effectiveness data…

• FDA approval · 2008-10-09
  FDA Approved: DANTRIUM — Supplemental Application (Par Health USA, LLC)

  FDA approved a supplemental application for Dantrium (dantrolene sodium) from Par Health USA, LLC, under NDA 018264.

• CLINICAL_TRIALS research · 2008-03-28
  Clinical Trial Update: Prevalence of Spasticity in Adults With Mental Retardation Living in the Community

  A completed Vanderbilt University clinical trial examined how prevalent spasticity is among adults with intellectual disability living in th…

• CLINICAL_TRIALS trial_result · 2008-02-26
  Clinical Trial Update: Randomized Double Blind Cross Over Study for Nabilone in Spasticity in Spinal Cord Injury Persons [Phase 2]

  Phase 2 randomized, double-blind, cross-over trial evaluating nabilone for spasticity in people with spinal cord injury was completed.

• CLINICAL_TRIALS trial_result · 2007-11-19
  Clinical Trial Update: Dutch National ITB Study in Children With Cerebral Palsy [Phase 3]

  A Phase 3 trial evaluating intrathecal baclofen for cerebral palsy-related spasticity in children has completed in the Netherlands.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2007-08-20
  Clinical Trial Update: Vanderbilt University Spasticity Management Program Evaluation Plan [Phase 4]

  This document provides an update on Vanderbilt University's Phase 4 Spasticity Management Program Evaluation Plan, with the trial status lis…

• FDA approval · 2006-07-28
  FDA Approved: ZANAFLEX — Supplemental Application (Covis Pharma US, Inc)

  The FDA approved a supplemental application for ZANAFLEX (tizanidine hydrochloride) submitted by Covis Pharma US, Inc.